Skip to main content
Premium Trial:

Request an Annual Quote

Swift Biosciences Accel-NGS Unique Dual Indexing Kit

Swift Biosciences has announced the release of its Accel-NGS Unique Dual Indexing Kit. Developed in a set of 96 dual indices for both i7 and i5 positions, the indexing kits improve misassignment rates to less than a percent and enable multiple applications including whole-genome sequencing, as well as whole-exome and methylation analysis. In addition, Swift's kits allow a scalable workflow for low-frequency somatic variant discovery, formalin-fixed paraffin-embedded analysis, microbial detection in human samples, and cell-free DNA analysis. The kits are compatible with any Illumina sequencing platform.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.